Close
Help




JOURNAL

Clinical Medicine Insights: Gastroenterology

Constipation, IBS and the 5-HT4 Receptor: What Role for Prucalopride?

Submit a Paper


Clinical Medicine Insights: Gastroenterology 2010:3 21-33

Review

Published on 20 Dec 2010

DOI: 10.4137/CGast.S4136


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Gastroenterology

Abstract

After the problems associated with the non-selective 5-HT4 receptor agonists cisapride and tegaserod, the 5-HT4 receptor is now beginning to come in from the cold. Thus, prucalopride is now the first of a new class of drug defined by selectivity and high intrinsic activity at the 5-HT4 receptor. Prucalopride has been developed for treatment of chronic constipation rather than constipation-predominant irritable bowel syndrome (IBS). This follows the trend of first evaluating new gastrointestinal (GI) prokinetic drugs in disorders where disrupted GI motility is known to exist, rather than in a functional bowel disorder where changes in motility are uncertain. If prucalopride is not progressed towards the IBS indication, it has at least shown the way for other selective 5-HT4 receptor agonists. Most notable among these is TD-5108 (velusetrag), also characterized by good selectivity at the 5-HT4 receptor, high intrinsic activity and efficacy in patients with chronic constipation.



Downloads

PDF  (585.28 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)


Sharing


What Your Colleagues Say About Clinical Medicine Insights: Gastroenterology
I had a really positive experience publishing in Clinical Medicine Insights: Gastroenterology.  The submission process is easy and friendly.  The review process is very accurate with a considerable quantity of reviewers who give helpful and reasonable suggestions.  The staff are professional and gives prompt email responses.  I recommend colleagues to consider publishing with Libertas Academica.
Dr Vincenzo Neri (University of Foggia, Foggia, Italy)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube